HNSBF - Hansa Biopharma AB (publ) (HNSBF) CEO Søren Tulstrup on Q4 2021 Results - Earnings Call Transcript

Hansa Biopharma AB (publ) (HNSBF) Q4 2021 Earnings Conference Call February 3, 2022 8:0 a.m. ET Company Participants Søren Tulstrup - President & CEO Donato Spota - CFO Klaus Sindahl - IR Conference Call Participants Christopher Uhde - SEB Adam Karlsson - ABG Sundal Collier Johan Unnerus - Redeye Zoe Karamanoli - RBC Capital Markets Dominic Rose - Intron Health Douglas Tsao - H.C. Wainwright Presentation Operator Hell, everyone, and welcome to the Hansa Biopharma year-end report for January through December 2021. For the first part of this call, all participants will be in listen-only mode, and afterwards there will be a question-and-answer session. Today, I'm pleased to present CEO, Søren Tulstrup. Speakers, please begin. Søren Tulstrup Thank you, operator. Good afternoon, good morning, and welcome to the Hansa Biopharma conference call reporting the year-end results for 2021. I'm Søren Tulstrup, CEO of Hansa Biopharma. With me today, I have

For further details see:

Hansa Biopharma AB (publ) (HNSBF) CEO Søren Tulstrup on Q4 2021 Results - Earnings Call Transcript